Biotechs With No Drugs in Trial Are Raising Millions in IPOs
Biotech IPOs are on track for a near-record year, with a crop of offerings that are younger, more highly valued—and some say riskier—than any in recent memory......»»
Some doctors are reportedly hoarding trial coronavirus drugs by issuing prescriptions for themselves
Reuters Some doctors around the country are hoarding medicine that could.....»»
Investor who took Virgin Galactic public raising nearly $1 billion in two new IPOs
Chamath Palihapitiya, who used a previous blank-check initial public offering to place Virgin Galactic Holdings Inc. on the public markets, has filed.....»»
Banks are handing out beefed-up credit lines no one asked for
It might sound like a risky strategy at a time when millions of Americans are drowning in debt: keep raising the limit on people’s credit cards, even if they don’t ask......»»
Banks are handing out beefed-up credit lines no one asked for
It might sound like a risky strategy at a time when millions of Americans are drowning in debt: keep raising the limit on people’s credit cards, even if they don’t ask......»»
Former top stockbroker "built business on lies," says prosecutor
A former financial planner who was kicked out of the securities industry and ordered to pay millions of dollars in damages to customers he allegedly tricked into high-risk investments went on trial Monday on criminal fraud charges......»»
Millions of children receive unnecessary medical care, including prescription drugs, cervical-cancer screenings and antibiotics
Health-care professionals advise parents to ask doctors they are jumping to the most extreme treatment and to enquire about the risks of any suggested care......»»
Pharmaceutical companies celebrated New Year"s by raising the prices on more than 250 drugs
Reuters Drugmakers including Bristol-Myers Squibb Co, Gilead Sciences Inc, and Biogen Inc hiked US list prices on more than 250 drugs on Wednesday. Some of the drugs that will be more expensive include blood thinner Eliquis, HIV.....»»
Ghosn flees to Lebanon, says won"t be "held hostage" by Japan"s justice system
Ousted Nissan boss Carlos Ghosn confirmed he fled to Lebanon, saying he wouldn't be "held hostage" by a "rigged" system, raising questions about how one of the world's most-recognized executives slipped out of Japan months before his trial......»»
Ex-Nissan boss Ghosn says he is in Lebanon, fleeing Japan"s "rigged" justice system
Ousted Nissan boss Carlos Ghosn confirmed he fled to Lebanon, saying he wouldn't be "held hostage" by a "rigged" justice system and raising questions about how one of the world's most-recognized executives escaped Japan months before his trial......»»
Ex-Nissan boss Ghosn says he is in Lebanon, denies fleeing justice in Japan
Ousted Nissan boss Carlos Ghosn has confirmed he is in Lebanon saying he refused to be "held hostage" by a "rigged" Japanese justice system, raising questions about how one of the world's most-recognized executives exited Japan months before his trial......»»
Ex-Nissan boss Ghosn, who was awaiting trial in Japan, now in Lebanon: source
Ousted Nissan boss Carlos Ghosn was in Lebanon as of Monday, according to a person familiar with the matter, raising questions about how one of the world's most recognized businessmen exited Japan months before his trial......»»
4 More Biotechs With Blockbuster Potential
Akero, Dermira, Global Blood Therapeutics and Moderna all have drugs that could hit $1 billion in salesRelated Stocks: AKRO, DERM, RHHBY, GBT, NVS, MRNA, MORF,.....»»
Elon Musk, at defamation trial, blames "pedo guy" tweet on overwork
Elon Musk said he was overworked when he called a British diver and cave explorer a "pedo guy" in a tweet to his millions of followers, as the Tesla chief executive defended himself on Wednesday at his defamation trial......»»
UPDATE: Evofem Biosciences stock soars 27% premarket on news of positive results in trial of drugs for STDs
Evofem Biosciences Inc. reported positive results in a mid-stage trial of a treatment for chlamydia and gonorrhea in women, sending its stock up 27% in premarket trade Monday. The San Diego-based company said a phase 2b study of amphora for pre.....»»
The Week Ahead In Biotech: Pfenex And Clinuvel On The Radar Ahead of FDA Decisions, 2 IPOs On Deck
Notwithstanding the ESMO conference generating some huge moves in some stocks, last week turned out to be a muted one for biotechs. read more.....»»
Capitol Report: Trump campaign capitalizes on impeachment threat, raising millions from supporters this week
The Trump 2020 campaign has been working this week to capitalize on the impeachment inquiry launched by House Speaker Nancy Pelosi, asking donors to contribute to an “Impeachment Defense Task Force†and attracting millions of dollars in donations......»»
Banker tells German fraud trial he made millions from "astronomical" trades
A British investment banker at the center of Germany's biggest fraud trial told judges on Thursday he earned millions of euros from deals involving "astronomical" trades that prosecutors say were a means to make bogus tax reclaims......»»
Banker tells German court of "vast network" at center of fraud trial
A banker at the center of a trading scheme German prosecutors say resulted in hundreds of millions of euros of illegitimate tax rebates told a court the scheme had taken on an "industrial scale" involving a network of banks and other institutions......»»
7 Biotechs With Catalysts in the Next Month
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October......»»
Why insurance-tech companies are piling into Austin, raising millions of dollars
These insurance-tech companies don't actually underwrite any policies. But they enable people and companies to buy health insurance, and often save a lot of money while doing so. Find out why they're so hot on Austin......»»